03504nam 2201105z- 450 991056645820332120220506(CKB)5680000000037799(oapen)https://directory.doabooks.org/handle/20.500.12854/80955(oapen)doab80955(EXLCZ)99568000000003779920202205d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierBiomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases ManagementBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (208 p.)3-0365-3746-5 3-0365-3745-7 This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.Medicine and Nursingbicsscadipokinesadiponectinantiplatelet therapybone turnover markersbreast cancercardiovascular diseasecase control studyCCL11CCL24CCL26CCR3CRCCrohn's diseaseCrohn's disease (CD)CTX-Idendritic cellsdiabetesextracellular matrixextracellular matrix componentsFSHRhedgehog-interacting proteinhyaluronanhyaluronan (HA)impaired fasting glucoseimpaired glucose toleranceinflammatory bowel diseaseinflammatory bowel diseases (IBD)innate lymphoid cellsinterleukin 21interleukin 22Let-7elymphocytesmacrophagesmicroRNAmiR-125a-3pmiR-126miR-223mortalitynewly diagnosed diabetesNGS variantsnormal glucose toleranceNTX-Iobesityovarian canceroverweightpersonalized drug therapypersonalized medicinepharmacogenomicsPICPPINPplatelet reactivityproteinsRANKL/OPGrheumatoid arthritisrheumatologysoluble part of syndecan-1 (sCD138)sulfated glycosaminoglycans (sGAG)TNF-α inhibitorstumor microenvironmenttumorigenesisulcerative colitisulcerative colitis (UC)Medicine and NursingKomosinska-Vassev Katarzynaedt1319548Olczyk PaweledtKomosinska-Vassev KatarzynaothOlczyk PawelothBOOK9910566458203321Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management3033952UNINA